Sales of Substances Injected into Knee to Treat Osteoarthritis Are Exempt in New York

Tuesday, August 7th, 2012

 
 
Share
Link
New York
General

The New York Department of Taxation and Finance (DTF) recently released an advisory opinion concluding that sales of substances injected into knee to treat osteoarthritis are exempt. N.Y. Advisory Op. of the Commr. of Taxn. and Fin. TSB-A-12(16)S (July 5, 2012).

The taxpayer that petitioned the DTF for the opinion explained how three products--Orthovisc, Euflexxa, and Hyalgan--are used to treat osteoarthritis of the knee. These products are administered by physicians as a series of injections into the knee. A healthy knee is surrounded by a joint fluid that acts as a shock absorber to cushion and protect the knee, but a knee damaged by osteoarthritis has little joint fluid, which causes pain. These products contain hyaluronan or hyaluronic acid (HA), which are naturally derived substances that supplement the knee's fluid, which helps to relieve the pain associated with osteoarthritis. The petitioner asked the DTF whether these products are exempt from sales tax.

New York exempts sales of the following: (1) drugs and medicines intended for use treatment or prevention of illness or disease in human beings; (2) medical equipment (including component parts thereof) and supplies required for such use or to correct or alleviate physical incapacity; and (3) products consumed by humans for the preservation of health. N.Y. Tax Law sec. 1115(a)(3); see also 20 N.Y. Comp. Codes R. and Regs. 528.4[b][3]. The DTF reasoned that when these three substances are injected into the knee, they supplement the knee's fluid, and, thus, improve the operation of the knee, and, thereby, maintain the patient's mobility. Accordingly, the DTF concluded that Orthovisc, Euflexxa, and Hyalgan are exempt because they are products consumed by humans for the preservation of health.

We previously reported on an opinion released by the DTF discussing Synvisc, a product similar to the three discussed in this article. Also note that, although the DTF's opinion did not use these terms, these products are commonly referred to as "viscosupplements," and the related treatment is known as "viscosupplementation."


About TTR

Transaction (buying or selling things), Tax (the tax on this activity), Resources (our people, our website, our support services) - TTR, Inc.

TTR has a website that companies subscribe to and use daily. This website provides a list of everything that can be bought or sold in the U.S. It provides simple answers to whether buying or selling these items is taxable (subject to a sales tax or other tax), and it provides all the legal authority to support these tax answers.

TTR likes to keep things simple and fun, which is why it has great people who provide help to clients on any support questions they have about transaction tax issues.

Please visit TTR on the web at www.ttrus.com or call 866.578.8193.

Vehicles Used to Transport Materials between Facilities...

Wednesday, August 15th, 2018 -The Arkansas Department of Finance and Administration recently ruled that a vehicle used to transport in-proce...

Economic Nexus in Washington

Monday, August 13th, 2018 -Effective October 1, 2018, certain out-of-state businesses will be required to collect and pay Washington sale...

Economic Nexus in Michigan

Thursday, August 9th, 2018 -Effective October 1, 2018, certain out-of-state sellers will be required to collect and pay Michigan sales or ...

Georgia Suspends Tax on Jet Fuel

Wednesday, August 8th, 2018 -Effective August 1, 2018, Georgia no longer collects state level sales and use tax on jet fuel. Georgia tax...

Employment Services Contracts for Permanent Employees Not...

Monday, August 6th, 2018 -The Ohio Board of Tax Appeals recently addressed whether contracts entered into by an employment services agen...

Alarm Systems and Monitoring Not Taxable in Missouri

Wednesday, August 1st, 2018 -The Missouri Department of Revenue recently released a ruling determining that (1) security, fire, tornado, an...